Kopran Limited (NSE:KOPRAN)

Market Cap	6.43B -29.0%
Revenue (ttm)	6.20B -3.7%
Net Income	165.43M -65.2%
EPS	3.42 -65.3%
Shares Out	n/a
PE Ratio	38.88
Forward PE	n/a
Dividend	3.00 (2.27%)
Ex-Dividend Date	Sep 4, 2025

Volume	188,511
Average Volume	183,167
Open	133.10
Previous Close	133.37
Day's Range	133.10 - 137.51
52-Week Range	119.81 - 214.00
Beta	0.39
RSI	46.51
Earnings Date	Jan 22, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 1,024
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KOPRAN

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.